Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nrc Health (NRC) Intangibles (2016 - 2026)

Nrc Health's Intangibles history spans 16 years, with the latest figure at $15.3 million for Q4 2025.

  • On a quarterly basis, Intangibles rose 8.43% to $15.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.3 million, a 8.43% increase, with the full-year FY2025 number at $15.3 million, up 8.43% from a year prior.
  • Intangibles hit $15.3 million in Q4 2025 for Nrc Health, up from $2.3 million in the prior quarter.
  • Over the last five years, Intangibles for NRC hit a ceiling of $15.3 million in Q4 2025 and a floor of $280000.0 in Q4 2023.
  • Historically, Intangibles has averaged $5.3 million across 5 years, with a median of $2.2 million in 2021.
  • Biggest five-year swings in Intangibles: soared 5825.11% in 2021 and later crashed 96.76% in 2022.
  • Tracing NRC's Intangibles over 5 years: stood at $13.0 million in 2021, then crashed by 96.76% to $420000.0 in 2022, then tumbled by 33.33% to $280000.0 in 2023, then soared by 4947.86% to $14.1 million in 2024, then grew by 8.43% to $15.3 million in 2025.
  • Business Quant data shows Intangibles for NRC at $15.3 million in Q4 2025, $2.3 million in Q3 2025, and $2.4 million in Q2 2025.